Mesna Injection bulk supplier for pharma manufacturers

Mesna Injection 100 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg/mL

Reference Brands: Mesnex(US)

Mesna inactivates harmful metabolites of cyclophosphamide and ifosfamide, reducing the risk of hemorrhagic cystitis. It binds to acrolein in the urinary bladder, protecting the lining. Benefits include preventing bladder toxicity, supporting continuous chemotherapy, and ensuring patient safety during high-dose cyclophosphamide or ifosfamide treatment.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Mesna injection, marketed as Mesnex, is approved in the US by the FDA and in the EU via EMA to prevent hemorrhagic cystitis during chemotherapy. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA conducts a comprehensive review, while the EMA assesses compliance with regional safety and quality standards. For guidance on dossier preparation, regulatory pathways, and successful market access, visit PharmaTradz. Ensuring regulatory compliance is essential for the safe, effective, and timely approval of mesna injection worldwide, supporting optimal patient care in oncology treatments.

Mesna Injection — third party manufacturing & bulk supply

Mesna Injection 100 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Mesna Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Mesna Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Mesna Injection →

Back to Listing

Frequently Asked Questions

Mesna Injection is listed as Injection in 100 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Mesna Injection is referenced against Mesnex(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.